Candidate vaccine by SII, Oxford varsity to join Ebola trial: WHO
The candidate vaccine developed by the Oxford University and the Serum Institute of India is among the two such vaccines added to the ongoing Ebola clinical trials, according to a World Health Organisation (WHO) statement, making it the first addition of candidate vaccines to the trials specifically targeting the Bundibugyo virus that has caused the current Ebola outbreak in the Democratic Republic of the Congo (DRC).
- ✓The candidate vaccine developed by the Oxford University and the Serum Institute of India is among the two such vaccines added to the ongoing Ebola clinical trials, according to a World Health Organisation (WHO) statement, making it the first addition of candidate vaccines to the trials specifically targeting the Bundibugyo virus that has caused the current Ebola outbreak in the Democratic Republic of the Congo (DRC).
- ✓Primary Authority: Official communique verified from Hindustan Times India.
- ✓Civic Domain: Categorized under health public notices.
The candidate vaccine developed by the Oxford University and the Serum Institute of India is among the two such vaccines added to the ongoing Ebola clinical trials, according to a World Health Organisation (WHO) statement, making it the first addition of candidate vaccines to the trials specifically targeting the Bundibugyo virus that has caused the current Ebola outbreak in the Democratic Republic of the Congo (DRC).
According to the formal briefing communicated by Hindustan Times India, this announcement has been instituted to ensure enhanced transparency, efficiency, and public accessibility across civic and administrative operations. The issuing authority has instructed all affiliated directorates and nodal offices to adhere strictly to the notified procedural roadmap.
This policy and administrative communique directly impacts citizens and aspirants navigating health, public sector career pathways, and institutional programs. Comprehensive guidelines, eligibility caveats, and official procedural calendars are being disseminated through verified channels. Stakeholders are strongly encouraged to rely on verified government communiques to avoid misinformation.
- •Aspirants and citizens are advised to monitor official notices and circulars issued by Hindustan Times India.
- •Verify all prescribed eligibility criteria, cutoff dates, and authenticated document requirements prior to formal submissions.
- •Track connected examination timetables, vacancy advisories, and administrative gazettes on SuchnaSetu.
| Issuing Authority | Hindustan Times India |
|---|---|
| Topic Category | HEALTH |
| Jurisdiction | All India / National |
| Publication Date | 17 November 2026 |